Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0001213900-19-020261
Filing Date
2019-10-11
Accepted
2019-10-11 21:16:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 8717
2 GRAPHIC image_001.jpg GRAPHIC 8549
  Complete submission text file 0001213900-19-020261.txt   21554
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations